I am currently a third year undergraduate student at Emory University studying Biology and Religion while on the pre-med track. I am also presently the Digital Marketing and Communications Intern at enlightenbio due to...read more
Latest news and articles
AGBT 2021 – A Virtual Summary with Spatial Profiling Dominating
AGBT 2021 took place virtually this year! But the conference was nevertheless the attention grabber of the week with a twitter storm, active reporting, and several commercial product launches as demonstrated by a slew...read more
Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics
New, qualitative report provides an in-depth analysis across the complex, multi-step clinical genomics data process, including genomic data generation and analysis, data flow, and data warehousing. Palo Alto, CA...read more
2020 Was Not Just About COVID-19
Certainly, the coronavirus and, with that COVID-19, has dominated 2020 and massively impacted not only our daily lives, but also the medical health care community and healthcare facilities in particular. Genomics proved...read more
The Role of the Human Gut Microbiome in Type 1 Diabetes
The human microbiome – which is the sum of all the microorganism that live in conjunction with the human body – includes eukaryotes, archaea, bacteria as well as the viruses and phages that infect them. Not...read more
Gene Editing Revamped with CRISPR Prime Editor – Result Is A High Efficiency, More Precise Gene Editor With Versatile Editing Capabilities And Lower Off-Target Effects
In October 2018 we published a blog (CRISPR Base Editors: An Upgrade for Treatment of Genetic Disease) describing some of the concerns surrounding the use of the CRISPR technology, and highlighting a relatively new...read more
BC Platforms Aims to Advance Clinical Decision-Making by Enhancing Clinical Data with Genomics Information
This month’s “Company Spotlight” provides a closer look at the Finnish-Swiss company BC Platforms, a genomic data management and analysis solutions provider, working to revolutionize drug development and to enable...read more
Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment
For this month’s “Company Spotlight” blog series we are reviewing Nebion, a Swiss bioinformatics company, in an interview with Philip Zimmermann, Co-founder and CEO of Nebion. Nebion is a 30-person company headquartered...read more
Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”
The following is an interview I recently conducted for the PMWC Intl. team with Dr. Mike Pellini, Managing Partner of Section 32 (former CEO of Foundation Medicine), and in essence is a repost of the original interview...read more
Othram Aims to Overcome DNA Sequencing Challenges to Solve Forensic Crime Cases
This month’s “Company Spotlight” takes a closer look at Othram Inc which applies the power of modern sequencing technology and genomics to forensics. David Mittelman, Chief Executive Officer of Othram, discussed with us...read more
